We have investigated the efficacy of anti-HBs human immunoglobulin (HBIG) in accidental exposures to HBV, and 3 cases that developed HBV infection in spite of passive immunization by HBIG were compared with 12 patients with acute hepatitis type B without HBIG immunization in their clinical features.
Anti-HBs were detected by radioimmunoassay in all samples obtained within 16 weeks and became undetectable by 24 weeks after passive immunization. The incidence of the development to acute hepatitis type B in spite of HBIG immunization was 0.8% (only one of 128) in our hospital.
All of the three cases that developed acute hepatitis type B despite immunization were infected by HBe antigen positive blood in accidental needle stick and they presented less severe clinical features than those without HBIG. Overt jaundice was acknowledged in only one patient, the peak value of serum total bilirubin was significanity lower and the mean period of incubation time was significantly prolonged.
These observation suggests the efficacy of HBIG and the necessity of longer follow-up more than 6 months after immunization in accidental exposures to HBV.
